{"disease":{"id":"visual-field-defect-following-cerebrovascular-accident","name":"visual field defect following cerebrovascular accident"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07317739","title":"Screening and Rehabilitation of Visual Field Defects in Post-Stroke Patients","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Fondazione David Chiossone - Impresa Sociale","has_results":false},{"nct_id":"NCT06341777","title":"Multisensory Telerehabilitation for Visual Field Defects","phase":"NA","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Istituto Auxologico Italiano","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}